Stocks and Investing Stocks and Investing
Fri, November 3, 2023

Kostas Biliouris Maintained (BMRN) at Buy with Decreased Target to $100 on, Nov 3rd, 2023


Published on 2024-10-28 07:20:09 - WOPRAI, Kostas Biliouris
  Print publication without navigation


Kostas Biliouris of BMO Capital, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $102 to $100 on, Nov 3rd, 2023.

Kostas has made no other calls on BMRN in the last 4 months.



There are 15 other peers that have a rating on BMRN. Out of the 15 peers that are also analyzing BMRN, 6 agree with Kostas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • William Pickering of "Bernstein" Upgraded from Sell to Hold and Held Target at $82 on, Monday, October 23rd, 2023
  • Laura Chico of "Raymond James" Initiated at Hold on, Thursday, September 28th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $100 on, Wednesday, September 13th, 2023
  • Andreas Argyrides of "Wedbush" Maintained at Hold with Decreased Target to $70 on, Tuesday, August 1st, 2023
  • George Farmer of "Scotiabank" Initiated at Hold and Held Target at $95 on, Thursday, July 27th, 2023
  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Decreased Target to $104 on, Monday, July 3rd, 2023


These are the ratings of the 9 analyists that currently disagree with Kostas


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $115 on, Thursday, November 2nd, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $111 on, Thursday, November 2nd, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $117 on, Thursday, November 2nd, 2023
  • Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $100 on, Thursday, November 2nd, 2023
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $140 on, Monday, September 25th, 2023
  • Martin Auster of "UBS" Initiated at Strong Buy and Held Target at $120 on, Monday, September 18th, 2023
  • Debjit Chattopadhyay of "Guggenheim" Reiterated at Strong Buy and Held Target at $110 on, Wednesday, September 13th, 2023
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $108 on, Tuesday, August 1st, 2023
  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $185 on, Friday, July 21st, 2023
Contributing Sources